On the potential cusp of FDA approval for its rare disease gene therapy, Orchard Therapeutics is being purchased by Japanese pharma Kyowa Kirin for close to $478 million if all conditions are met, the companies announced on Thursday.
Tag Archive for: Kyowa Kirin
Shares of ChemoCentryx are skyrocketing in premarket trading after the company announced it will be acquired by Amgen in a $4 billion deal that will bring Tavneos, a first-in-class treatment for ANCA-associated vasculitis, into the company’s portfolio.